FCGR2A and acute disseminated encephalomyelitis: Together, the exclusion of prM, maintenance of native E protein structure, and an immunoglobulin response less prone to pathological FcγR engagement all contribute to the markedly lower risk of ADE with dengue VLP vaccines.